§300ff–11. Establishment of program of grants
(a) Eligible areas
The Secretary, acting through the Administrator of the Health Resources and Services Administration, shall, subject to subsection (b) of this section, make grants in accordance with section 300ff–13 of this title for the purpose of assisting in the provision of the services specified in 1 300ff–14 of this title in any metropolitan area for which, as of June 30, 1990, in the case of grants for fiscal year 1991, and as of March 31 of the most recent fiscal year for which such data is available in the case of a grant for any subsequent fiscal year-
(1) there has been reported to and confirmed by the Director of the Centers for Disease Control and Prevention a cumulative total of more than 2,000 cases of acquired immune deficiency syndrome; or
(2) the per capita incidence of cumulative cases of such syndrome (computed on the basis of the most recently available data on the population of the area) is not less than 0.0025.
(b) Requirement regarding confirmation of cases
The Secretary may not make a grant under subsection (a) of this section for a metropolitan area unless, before making any payments under the grant, the cases of acquired immune deficiency syndrome reported for purposes of such subsection have been confirmed by the Secretary, acting through the Director of the Centers for Disease Control and Prevention.
(July 1, 1944, ch. 373, title XXVI, §2601, as added Aug. 18, 1990,
Prior Provisions
A prior section 2601 of act July 1, 1944, was successively renumbered by subsequent acts and transferred, see section 238 of this title.
Amendments
1992-Subsecs. (a)(1), (b).
Study Regarding HIV Disease in Rural Areas
Section 403 of
"(a)
"(1) conduct a study for the purpose of estimating the incidence and prevalence in rural areas of cases of acquired immune deficiency syndrome and cases of infection with the etiologic agent for such syndrome; and
"(2) in carrying out such study, determine the adequacy in rural areas of services for diagnosing such cases and providing treatment for such cases that are in the early stages of infection.
"(b)
"(c)
Section Referred to in Other Sections
This section is referred to in sections 300ff–12, 300ff–13, 300ff–14, 300ff–15, 300ff–17, 300ff–47 of this title.